Novartis (United Kingdom)

955 papers and 44.4k indexed citations i.

About

In recent decades, authors affiliated with Novartis (United Kingdom) have published 955 papers, which have received a total of 44.4k indexed citations. Scholars at this organization have produced 268 papers in Physiology, 230 papers in Pulmonary and Respiratory Medicine and 227 papers in Molecular Biology on the topics of Asthma and respiratory diseases (190 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (71 papers) and Respiratory and Cough-Related Research (63 papers). Their work is cited by papers focused on Physiology (14.8k citations), Molecular Biology (11.0k citations) and Pulmonary and Respiratory Medicine (9.9k citations). Authors at Novartis (United Kingdom) collaborate with scholars in United Kingdom, United States and Switzerland and have published in prestigious journals including Nature, Science and Cell. Some of Novartis (United Kingdom)'s most productive authors include László Urbán, Paul Kirkham, Irfan Rahman, Stuart Bevan, Steven J. Charlton, Alyson Fox, Clive Gentry, Alexandre Trifilieff, David A. Andersson and Bruce Kidd.

In The Last Decade

Fields of papers published by authors at Novartis (United Kingdom)

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Novartis (United Kingdom) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Novartis (United Kingdom) at the time of their publication.

Countries citing scholars working at Novartis (United Kingdom)

Since Specialization

Citations

This map shows the geographic impact of research produced by authors working at Novartis (United Kingdom). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Novartis (United Kingdom) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Novartis (United Kingdom) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Breakdown of academic impact, for scholars at Sydney South West Area Health Service Breakdown of academic impact, for scholars at Retina Foundation of the Southwest Breakdown of academic impact, for scholars at Australian and New Zealand Intensive Care Society Breakdown of academic impact, for scholars at Kihara Institute for Biological Research Breakdown of academic impact, for scholars at MRC Weatherall Institute of Molecular Medicine Breakdown of academic impact, for scholars at Angeles Clinic and Research Institute Breakdown of academic impact, for scholars at Biologie et Gestion des Risques en Agriculture Breakdown of academic impact, for scholars at Social Insurance Institution